<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=35476375865279447&ev=PageView&noscript=1"/>

Colgate Palmolive (India) Limited

NSE: COLPAL · Lot size: 225

Colgate Palmolive (India) Limited Open Interest & PCR Analysis

2,078Updated 21 Apr 2026, 01:26 pm IST
PCR
0.67
Bearish signal
Max Pain
2,020
Spot above by ₹58
Total CE OI
2.32M
Call writers
Total PE OI
1.56M
Put writers
OI Buildup Signal
Neutral
Price movement < 0.3% threshold
Put-Call Ratio Gauge
0 — Bearish1.0 — Neutral2.0+ — Bullish

Data as of 2026-04-21

Frequently Asked Questions

What is Colgate Palmolive (India) Limited PCR (Put-Call Ratio) today?
Colgate Palmolive (India) Limited's current PCR is 0.67. A PCR above 1.2 is considered bullish (more put writing = floor support); below 0.8 is bearish; 0.8–1.2 is neutral. Colgate Palmolive (India) Limited's PCR of 0.67 indicates bearish sentiment.
What is Colgate Palmolive (India) Limited OI buildup type today?
Colgate Palmolive (India) Limited is currently showing neutral positioning with no significant directional bias. This is determined by comparing today's price change direction with the direction of total OI change — using the standard F&O buildup classification framework.
What is total CE and PE open interest for Colgate Palmolive (India) Limited?
Colgate Palmolive (India) Limited has total CE (call) OI of 2323350 contracts and total PE (put) OI of 1563300 contracts for the nearest expiry. The PCR is 0.67.
How is open interest analysis useful for Colgate Palmolive (India) Limited trading?
OI analysis for Colgate Palmolive (India) Limited helps identify institutional positioning. High CE OI at a strike = call writers defending that level (resistance). High PE OI = put writers defending that level (support). The buildup type tells you whether smart money is building fresh positions (bullish/bearish) or exiting existing ones.
What is the max pain for Colgate Palmolive (India) Limited?
Colgate Palmolive (India) Limited's max pain is ₹2,020 — the strike price where option writers (sellers) collectively suffer the least financial loss at expiry. The current spot price vs max pain deviation guides near-term directional bias into expiry.